Amyotrophic lateral sclerosis (ALS), also known as “Lou Gehrig’s Disease,” is a devastating fatal disease of the nervous system that kills two to five Canadians every day. On September 19th and 20th, the Montreal Neurological Institute and Hospital (The Neuro), at McGill University and the McGill University Health Centre will host the 10th Annual ALS Symposium of the Fondation André-Delambre. Nearly one hundred researchers and clinicians from several countries will come together to discuss recent progress in ALS research.
“Through this annual symposium, the Fondation Andre-Delambre set the stage for numerous collaborations including a pan-Canadian Phase II clinical trial targeting an immune response pathway,” said Professor Jean-Pierre Julien, renowned ALS expert at the Centre de recherche de l’IUSMQ, Universite Laval.
Journalists are invited to attend the symposium to learn more about this disease and the latest developments for new treatments.
Symposium speakers will join the Montreal Walk for ALS on Saturday, September 20 at 12 noon at Maisonneuve Park. There, they will also be available to discuss the latest findings on the causes of ALS and therapeutic avenues.
Date: Friday, September 19, 2014 – Saturday, September 20, 2014
Place: Jeanne Timmins Amphitheatre, Montreal Neurological Institute and Hospital, 3801 University Street, Montreal
Presenters at the two-day symposium include:
- Jean-Pierre Julien, PhD - Université Laval
- Guy Rouleau, MD, PhD – Montreal Neurological Institute and Hospital
- Angela Genge, MD - Montreal Neurological Institute and Hospital
- Lorne Zinman, MD, PhD - University of Toronto
- and other internationally renowned ALS experts